Filing Flows › Comparisons › FOFA vs HRGN
Family Office of America vs Harvard Apparatus Regenerative Technology: FOFA and HRGN compared
Family Office of America is the larger company: $533K of revenue in its latest quarter (Q2 2026) against $414K for Harvard Apparatus Regenerative Technology (Q2 2026). Family Office of America is more profitable, with an operating margin of -29.0% against -408.7%.
Where the money goes: FOFA and HRGN
Family Office of America (FOFA) · Q2 2026
Family Office of America, Q2 2026: revenue $533K, operating margin -29.0%, net loss $125K, operating cash flow $149K. The chart follows the revenue to costs, profit and cash.
Harvard Apparatus Regenerative Technology (HRGN) · Q2 2026
Harvard Apparatus Regenerative Technology, Q2 2026: revenue $414K (+31% year over year), operating margin -408.7%, net loss $1.7M, operating cash flow −$569K. The chart follows the revenue to costs, profit and cash.
| Family Office of America (FOFA) | Harvard Apparatus Regenerative Technology (HRGN) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $533K | $414K |
| Revenue growth, Y/Y | — | +31% |
| Operating margin | -29.0% | -408.7% |
| Net earnings | −$125K | −$1.7M |
| Net margin | -23.5% | -409.4% |
| Operating cash flow | $149K | −$569K |
Where the revenue comes from
Family Office of America
- Toone & Associates, LLP: $437K (82%)
- Benson Family Office & Accounting Services, LLC: $95K (18%)
Questions
Which is bigger, Family Office of America or Harvard Apparatus Regenerative Technology?
Family Office of America is the larger company: $533K of revenue in its latest quarter (Q2 2026) against $414K for Harvard Apparatus Regenerative Technology (Q2 2026).
Is Family Office of America or Harvard Apparatus Regenerative Technology growing faster?
Family Office of America is more profitable, with an operating margin of -29.0% against -408.7%.
More: Family Office of America earnings · how Family Office of America makes money · Harvard Apparatus Regenerative Technology earnings · how Harvard Apparatus Regenerative Technology makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.